1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 HIS 1 - LYS 2 OMEGA = 0.21 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION LYS 2 - CYS 3 OMEGA =359.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION CYS 127 - SER 128 OMEGA = 0.12 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION SER 128 - SER 129 OMEGA = 0.02 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION Redfield, C. Smith, L.J. Boyd, J. Lawrence, G.M.P. Edwards, R.G. Gershater, C.J. Smith, R.A.G. Dobson, C.M. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 238 23 41 10.1006/jmbi.1994.1265 8145254 Analysis of the solution structure of human interleukin-4 determined by heteronuclear three-dimensional nuclear magnetic resonance techniques. 1994 UK J.Mol.Biol. JMOBAK 0070 0022-2836 224 899 Human Interleukin 4: The Solution Structure of a Four-Helix-Bundle Protein 1992 US Biochemistry BICHAW 0033 0006-2960 30 11029 Secondary Structure and Topology of Human Interleukin 4 in Solution 1991 10.2210/pdb1itm/pdb pdb_00001itm 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 15120.445 INTERLEUKIN-4 1 man polymer no no MHKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKNTTEKETFCRAATVLRQFYSHHEKDTRCLGATAQQFHRHKQL IRFLKRLDRNLWGLAGLNSCPVKEANQSTLENFLERLKTIMREKYSKCSS MHKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKNTTEKETFCRAATVLRQFYSHHEKDTRCLGATAQQFHRHKQL IRFLKRLDRNLWGLAGLNSCPVKEANQSTLENFLERLKTIMREKYSKCSS A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample 9606 Homo sapiens database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1994-05-31 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1994-02-28 REL 1 BRUNGER refinement X-PLOR MET 0 n 1 MET 0 A HIS 1 n 2 HIS 1 A LYS 2 n 3 LYS 2 A CYS 3 n 4 CYS 3 A ASP 4 n 5 ASP 4 A ILE 5 n 6 ILE 5 A THR 6 n 7 THR 6 A LEU 7 n 8 LEU 7 A GLN 8 n 9 GLN 8 A GLU 9 n 10 GLU 9 A ILE 10 n 11 ILE 10 A ILE 11 n 12 ILE 11 A LYS 12 n 13 LYS 12 A THR 13 n 14 THR 13 A LEU 14 n 15 LEU 14 A ASN 15 n 16 ASN 15 A SER 16 n 17 SER 16 A LEU 17 n 18 LEU 17 A THR 18 n 19 THR 18 A GLU 19 n 20 GLU 19 A GLN 20 n 21 GLN 20 A LYS 21 n 22 LYS 21 A THR 22 n 23 THR 22 A LEU 23 n 24 LEU 23 A CYS 24 n 25 CYS 24 A THR 25 n 26 THR 25 A GLU 26 n 27 GLU 26 A LEU 27 n 28 LEU 27 A THR 28 n 29 THR 28 A VAL 29 n 30 VAL 29 A THR 30 n 31 THR 30 A ASP 31 n 32 ASP 31 A ILE 32 n 33 ILE 32 A PHE 33 n 34 PHE 33 A ALA 34 n 35 ALA 34 A ALA 35 n 36 ALA 35 A SER 36 n 37 SER 36 A LYS 37 n 38 LYS 37 A ASN 38 n 39 ASN 38 A THR 39 n 40 THR 39 A THR 40 n 41 THR 40 A GLU 41 n 42 GLU 41 A LYS 42 n 43 LYS 42 A GLU 43 n 44 GLU 43 A THR 44 n 45 THR 44 A PHE 45 n 46 PHE 45 A CYS 46 n 47 CYS 46 A ARG 47 n 48 ARG 47 A ALA 48 n 49 ALA 48 A ALA 49 n 50 ALA 49 A THR 50 n 51 THR 50 A VAL 51 n 52 VAL 51 A LEU 52 n 53 LEU 52 A ARG 53 n 54 ARG 53 A GLN 54 n 55 GLN 54 A PHE 55 n 56 PHE 55 A TYR 56 n 57 TYR 56 A SER 57 n 58 SER 57 A HIS 58 n 59 HIS 58 A HIS 59 n 60 HIS 59 A GLU 60 n 61 GLU 60 A LYS 61 n 62 LYS 61 A ASP 62 n 63 ASP 62 A THR 63 n 64 THR 63 A ARG 64 n 65 ARG 64 A CYS 65 n 66 CYS 65 A LEU 66 n 67 LEU 66 A GLY 67 n 68 GLY 67 A ALA 68 n 69 ALA 68 A THR 69 n 70 THR 69 A ALA 70 n 71 ALA 70 A GLN 71 n 72 GLN 71 A GLN 72 n 73 GLN 72 A PHE 73 n 74 PHE 73 A HIS 74 n 75 HIS 74 A ARG 75 n 76 ARG 75 A HIS 76 n 77 HIS 76 A LYS 77 n 78 LYS 77 A GLN 78 n 79 GLN 78 A LEU 79 n 80 LEU 79 A ILE 80 n 81 ILE 80 A ARG 81 n 82 ARG 81 A PHE 82 n 83 PHE 82 A LEU 83 n 84 LEU 83 A LYS 84 n 85 LYS 84 A ARG 85 n 86 ARG 85 A LEU 86 n 87 LEU 86 A ASP 87 n 88 ASP 87 A ARG 88 n 89 ARG 88 A ASN 89 n 90 ASN 89 A LEU 90 n 91 LEU 90 A TRP 91 n 92 TRP 91 A GLY 92 n 93 GLY 92 A LEU 93 n 94 LEU 93 A ALA 94 n 95 ALA 94 A GLY 95 n 96 GLY 95 A LEU 96 n 97 LEU 96 A ASN 97 n 98 ASN 97 A SER 98 n 99 SER 98 A CYS 99 n 100 CYS 99 A PRO 100 n 101 PRO 100 A VAL 101 n 102 VAL 101 A LYS 102 n 103 LYS 102 A GLU 103 n 104 GLU 103 A ALA 104 n 105 ALA 104 A ASN 105 n 106 ASN 105 A GLN 106 n 107 GLN 106 A SER 107 n 108 SER 107 A THR 108 n 109 THR 108 A LEU 109 n 110 LEU 109 A GLU 110 n 111 GLU 110 A ASN 111 n 112 ASN 111 A PHE 112 n 113 PHE 112 A LEU 113 n 114 LEU 113 A GLU 114 n 115 GLU 114 A ARG 115 n 116 ARG 115 A LEU 116 n 117 LEU 116 A LYS 117 n 118 LYS 117 A THR 118 n 119 THR 118 A ILE 119 n 120 ILE 119 A MET 120 n 121 MET 120 A ARG 121 n 122 ARG 121 A GLU 122 n 123 GLU 122 A LYS 123 n 124 LYS 123 A TYR 124 n 125 TYR 124 A SER 125 n 126 SER 125 A LYS 126 n 127 LYS 126 A CYS 127 n 128 CYS 127 A SER 128 n 129 SER 128 A SER 129 n 130 SER 129 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A CB THR 6 WRONG HAND 1 A A HG1 H THR THR 39 40 1.31 1 A ARG 47 0.315 SIDE CHAIN 1 A ARG 53 0.240 SIDE CHAIN 1 A ARG 64 0.242 SIDE CHAIN 1 A ARG 75 0.287 SIDE CHAIN 1 A ARG 81 0.305 SIDE CHAIN 1 A ARG 85 0.186 SIDE CHAIN 1 A ARG 88 0.209 SIDE CHAIN 1 A ARG 115 0.292 SIDE CHAIN 1 A ARG 121 0.289 SIDE CHAIN 1 21.60 2.70 111.00 132.60 A A A N CA C CYS CYS CYS 3 3 3 N 1 -7.39 1.00 110.10 102.71 A A A CG CD1 NE1 TRP TRP TRP 91 91 91 N 1 8.16 0.90 109.00 117.16 A A A CD1 NE1 CE2 TRP TRP TRP 91 91 91 N 1 7.93 1.10 130.40 138.33 A A A NE1 CE2 CZ2 TRP TRP TRP 91 91 91 N 1 A LEU 7 -49.37 -70.82 1 A THR 22 -132.19 -152.22 1 A THR 28 -18.77 114.71 1 A ALA 35 -149.03 10.35 1 A LYS 37 -16.90 -61.58 1 A THR 39 -126.00 -166.38 1 A GLU 60 -25.09 -47.96 1 A THR 63 24.87 52.52 1 A THR 69 -158.42 -90.30 1 A ALA 70 -149.42 -51.25 1 A LEU 96 -128.67 -127.34 1 A ASN 97 -148.78 -59.51 1 A PRO 100 -69.69 -179.82 1 A LYS 102 -111.37 64.29 1 A GLU 103 -21.15 144.94 1 A ALA 104 -112.87 -77.87 1 A LEU 109 3.49 -61.15 1 A LYS 123 -69.57 2.19 1 A LYS 126 -95.72 46.14 1 A CYS 127 -136.13 -36.59 model building X-PLOR refinement X-PLOR phasing X-PLOR ANALYSIS OF THE SOLUTION STRUCTURE OF HUMAN INTERLEUKIN 4 DETERMINED BY HETERONUCLEAR THREE-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE TECHNIQUES 1 Y N A ILE 5 A ILE 6 HELX_P A GLU 19 A GLU 20 1 H1 15 A GLU 41 A GLU 42 HELX_P A HIS 59 A HIS 60 1 H2 19 A GLN 71 A GLN 72 HELX_P A ALA 94 A ALA 95 1 H3 24 A GLU 110 A GLU 111 HELX_P A SER 125 A SER 126 1 H4 16 disulf 2.019 A CYS 3 A SG CYS 4 1_555 A CYS 127 A SG CYS 128 1_555 disulf 2.020 A CYS 24 A SG CYS 25 1_555 A CYS 65 A SG CYS 66 1_555 disulf 2.019 A CYS 46 A SG CYS 47 1_555 A CYS 99 A SG CYS 100 1_555 CYTOKINE CYTOKINE A HIS 1 A HIS 2 1 A LYS 2 A LYS 3 0.21 A LYS 2 A LYS 3 1 A CYS 3 A CYS 4 -0.09 A CYS 127 A CYS 128 1 A SER 128 A SER 129 0.12 A SER 128 A SER 129 1 A SER 129 A SER 130 0.00 IL4_HUMAN UNP 1 1 P05112 MGLTSQLLPPLFFLLACAGNFVHGHKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKNTTEKETFCRAATVLRQFY SHHEKDTRCLGATAQQFHRHKQLIRFLKRLDRNLWGLAGLNSCPVKEANQSTLENFLERLKTIMREKYSKCSS 25 153 1ITM 1 129 P05112 A 1 2 130 2 anti-parallel A VAL 29 A VAL 30 A ASP 31 A ASP 32 A ASN 105 A ASN 106 A THR 108 A THR 109 1 P 1